Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones.
about
Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD)Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disordersInteractions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's diseaseAntioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatumWedelolactone Acts as Proteasome Inhibitor in Breast Cancer CellsDeficient vesicular storage: A common theme in catecholaminergic neurodegeneration.The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's diseaseProtective and toxic roles of dopamine in Parkinson's disease.Impact of Plant-Derived Flavonoids on Neurodegenerative Diseases.Induction of NQO1 and Neuroprotection by a Novel Compound KMS04014 in Parkinson's Disease Models.Glutathione transferase-M2-2 secreted from glioblastoma cell protects SH-SY5Y cells from aminochrome neurotoxicity.The Proteasome Inhibition Model of Parkinson's Disease.Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's diseaseOverexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity.Neuroprotective effects of 3α-acetoxyeudesma-1,4(15),11(13)-trien-12,6α-olide against dopamine-induced apoptosis in the human neuroblastoma SH-SY5Y cell line.Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.PCB95 and PCB153 change dopamine levels and turn-over in PC12 cells.
P2860
Q26752685-9BEFF72E-2AD8-49A3-9288-874B5660CA0EQ26826093-36D56690-91CB-436C-90A4-8EF5A92D0C77Q28391762-A3C73ACA-134D-44BA-8E9F-57C0205FE3F1Q28566901-60089B51-850D-48AC-80FA-06691819844CQ33624386-C6761CC3-4D2C-4103-A787-F0D4C277398EQ36011221-A012229A-741B-4126-BB8B-C1F268918805Q37845675-108E75A3-325D-4802-BA53-277862DF764CQ38189127-34CFB396-0491-4A8A-BFAB-69E59855BF0BQ38764212-C07B09A5-47AB-4B3E-8A11-5EF2B3BC2642Q38907367-7255EA1C-6D51-44CF-83CF-DF745E08341AQ38939870-90C6631F-4662-4369-8496-CB6D45056FC2Q38996038-E664C43C-1AB9-436F-9A76-78822AC74766Q39205712-0BA3B1D9-0F5D-42C7-B3AB-2DBF905D11E7Q39368224-48BF9CED-EC1F-4379-B0C6-80C4B7185E1BQ39521597-6B5E9DA9-586F-4B5B-AF55-96CA77F7623DQ43679571-E42FB7C6-2B0F-4989-9BC0-D26602B89142Q49887516-9DFA39C5-907E-490F-B143-0547B2DD7CAA
P2860
Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones.
@en
Dopamine
@nl
type
label
Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones.
@en
Dopamine
@nl
prefLabel
Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones.
@en
Dopamine
@nl
P2860
P1476
Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones.
@en
P2093
Tit Meng Lim
Zhi Dong Zhou
P2860
P304
P356
10.1080/10715760902801533
P577
2009-03-17T00:00:00Z